Forte Biosciences Inc (FBRX)

May 23, 2026

Forte Biosciences Q1 2026 Earnings: Pre-revenue Biotech Misses EPS Estimates; Stock Dips on Narrower Loss MissGlobal Trading Community - Newser

May 23, 2026

May 23, 2026

FBRX Q1 2026 Earnings: Wider-than-Expected Loss Reflects Pre-Revenue Biotech RealityLive Trade Sharing - Newser

May 23, 2026

May 22, 2026

FBRX Stock Price, Quote & Chart | FORTE BIOSCIENCES INC (NASDAQ:FBRX) - ChartMill

May 22, 2026

May 21, 2026

Forte Biosciences stock (US34960P1012): Q1 update keeps focus on skin disease pipeline - AD HOC NEWS

May 21, 2026

May 19, 2026

(FBRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily

May 19, 2026

May 19, 2026

Forte Biosciences Inc stock (US34960P1012): clinical pivot and cash focus keep biotech investors ale - AD HOC NEWS

May 19, 2026

May 18, 2026

Forte Biosciences (FBRX) price target increased by 19.72% to 65.02 - MSN

May 18, 2026

May 17, 2026

Forte Biosciences stock (US34960P1012): volatile biotech after recent sell-off tests investor nerves - AD HOC NEWS

May 17, 2026

May 16, 2026

Forte Biosciences stock (US34960P1012): New 13G filings highlight major holders - AD HOC NEWS

May 16, 2026

May 16, 2026

Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX) - Seeking Alpha

May 16, 2026

May 15, 2026

OrbiMed entities hold 5.8% of Forte Biosciences (FBRX), ownership split disclosed - Stock Titan

May 15, 2026

May 15, 2026

Point72 entities report 0% ownership in Forte Biosciences (FBRX) - Stock Titan

May 15, 2026

May 15, 2026

MPM BioImpact LLC takes a 7.2% position in Forte Biosciences (NASDAQ: FBRX) - Stock Titan

May 15, 2026

May 15, 2026

Alger Associates (NASDAQ: FBRX) reports 1.27M shares; 10.2% stake - Stock Titan

May 15, 2026

May 15, 2026

Janus Henderson (FBRX) discloses 9.99% holding; 299,798 pre-funded warrants - Stock Titan

May 15, 2026

May 14, 2026

Forte Biosciences (NASDAQ: FBRX) deepens Q1 loss while FB102 wins Fast Track - Stock Titan

May 14, 2026

May 14, 2026

Affinity Asset Advisors takes 7.3% stake in Forte Biosciences (NASDAQ: FBRX) - Stock Titan

May 14, 2026

May 14, 2026

Forte Biosciences stock (US34960P1012): Q1 2026 earnings report upcoming - AD HOC NEWS

May 14, 2026

May 13, 2026

Forte Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2026

May 13, 2026

Adage (FBRX) files Schedule 13G reporting 950,000-share stake - Stock Titan

May 13, 2026

May 13, 2026

FBRX Technical Analysis | Trend, Signals & Chart Patterns | FORTE BIOSCIENCES INC (NASDAQ:FBRX) - ChartMill

May 13, 2026

May 12, 2026

Forte Biosciences stock (US34960P1012): Q1 2026 results and FDA Fast Track for FB102 - AD HOC NEWS

May 12, 2026

May 12, 2026

Chardan Capital Maintains Forte Biosciences(FBRX.US) With Buy Rating, Maintains Target Price $61 - Moomoo

May 12, 2026

May 12, 2026

MSN Money - MSN

May 12, 2026

May 11, 2026

Forte Biosciences Grants 66,667 RSUs to New Employee as Inducement - geneonline.com

May 11, 2026

May 11, 2026

New Forte Biosciences hire gets 50K options, 50K RSUs to join - Stock Titan

May 11, 2026

May 11, 2026

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - The Joplin Globe

May 11, 2026

May 11, 2026

Forte Biosciences Releases Q1 2026 Financial Results - AlphaStreet

May 11, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 11, 2026

Forte Biosciences, Inc. 1Q 2026: Net loss $(22.1M), Diluted EPS $(1.24) — 10-Q Summary - TradingView

May 11, 2026

May 11, 2026

Forte Biosciences Q1 net loss narrows as R&D spending rises - TradingView

May 11, 2026

May 11, 2026

Forte Biosciences (FBRX) widens Q1 loss and raises $172.5M to fund FB102 trials - Stock Titan

May 11, 2026

May 11, 2026

Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update - The Joplin Globe

May 11, 2026

May 11, 2026

Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 11, 2026

May 11, 2026

FDA fast-tracks celiac treatment as Forte Biosciences raises $172M - Stock Titan

May 11, 2026

May 11, 2026

FBRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

May 11, 2026

May 10, 2026

Forte Biosciences (NASDAQ:FBRX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat

May 10, 2026

May 08, 2026

Responsive Playbooks and the FBRX Inflection - Stock Traders Daily

May 08, 2026

May 05, 2026

What Forte Biosciences (FBRX) is doing to earn customer loyalty (Breakdown Watch) 2026-05-05Wall Street Picks - newser.com

May 05, 2026

May 05, 2026

Evercore Maintains Forte Biosciences(FBRX.US) With Buy Rating, Maintains Target Price $65 - Moomoo

May 05, 2026

May 02, 2026

Wall Street Zen Upgrades Forte Biosciences (NASDAQ:FBRX) to "Sell" - MarketBeat

May 02, 2026

Apr 30, 2026

Stock Traders Purchase High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Apr 30, 2026

Apr 29, 2026

Forte Biosciences | DEF 14A: Definitive information statements - Moomoo

Apr 29, 2026

Apr 29, 2026

[ARS] Forte Biosciences, Inc. SEC Filing - Stock Titan

Apr 29, 2026

Apr 29, 2026

Forte Biosciences (NASDAQ: FBRX) 2026 proxy seeks approval of larger equity plan - Stock Titan

Apr 29, 2026

Apr 28, 2026

FBRX - Finviz

Apr 28, 2026

Apr 27, 2026

Is Forte Biosciences (FBRX) stock respecting technical levels | Q4 2025: Earnings Fall ShortCrowd Trend Signals - Newser

Apr 27, 2026

Apr 27, 2026

Understanding the Setup: (FBRX) and Scalable Risk - Stock Traders Daily

Apr 27, 2026

Apr 23, 2026

FBRX (Forte Biosciences Inc.) reports wider than expected Q4 2025 loss, with shares falling 3.52% following the earnings release.Financial Update - UBND thành phố Hải Phòng

Apr 23, 2026

Apr 18, 2026

Forte Biosciences Inc stock (US34960P1012): Is its immunology focus strong enough to unlock biotech - AD HOC NEWS

Apr 18, 2026

Apr 16, 2026

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update - MarketBeat

Apr 16, 2026